{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:34:37Z","timestamp":1774038877243,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Heart failure (HF) is associated with high mortality and affects men and women differently. The underlying mechanisms for these sex-related differences remain largely unexplored. Accordingly, using mice with cardiac-specific overexpression of the angiotensin II (ANGII) type 1 receptor (AT1R), we explored male-female differences in the manifestations of hypertrophy and HF. AT1R mice of both sexes feature electrical and Ca<jats:sup>2+<\/jats:sup>handling alterations, systolic dysfunction, hypertrophy and develop HF. However, females had much higher mortality (21.0%) rate than males (5.5%). In females, AT1R stimulation leads to more pronounced eccentric hypertrophy (larger increase in LV mass\/body weight ratio [+31%], in cell length [+27%], in LV internal end-diastolic [LVIDd, +34%] and systolic [LVIDs, +67%] diameter) and dilation (larger decrease in LV posterior wall thickness, +17%) than males. In addition, in female AT1R mice the cytosolic Ca<jats:sup>2+<\/jats:sup>extrusion mechanisms were more severely compromised and were associated with a specific increased in Ca<jats:sup>2+<\/jats:sup>sparks (by 187%) and evidence of SR Ca<jats:sup>2+<\/jats:sup>leak. Altogether, these results suggest that female AT1R mice have more severe eccentric hypertrophy, dysfunction and compromised Ca<jats:sup>2+<\/jats:sup>dynamics. These findings indicate that females are more susceptible to the adverse effects of AT1R stimulation than males favouring the development of HF and increased mortality.<\/jats:p>","DOI":"10.1038\/s41598-018-19436-5","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T12:53:55Z","timestamp":1515675235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Angiotensin II Overstimulation Leads to an Increased Susceptibility to Dilated Cardiomyopathy and Higher Mortality in Female Mice"],"prefix":"10.1038","volume":"8","author":[{"given":"Sophie","family":"Mathieu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"El Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katy","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Nemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Fiset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"19436_CR1","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cardiores.2007.03.025","volume":"75","author":"E Murphy","year":"2007","unstructured":"Murphy, E. & Steenbergen, C. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res 75, 478\u2013486 (2007).","journal-title":"Cardiovasc Res"},{"key":"19436_CR2","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1161\/CIRCRESAHA.116.307547","volume":"118","author":"M Garcia","year":"2016","unstructured":"Garcia, M., Mulvagh, S. L., Merz, C. N. B., Buring, J. E. & Manson, J. E. Cardiovascular Disease in Women: Clinical Perspectives. Circ. Res. 118, 1273\u20131293 (2016).","journal-title":"Circ. Res."},{"key":"19436_CR3","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.jacc.2009.04.098","volume":"54","author":"LJ Shaw","year":"2009","unstructured":"Shaw, L. J., Bugiardini, R. & Merz, C. N. B. Women and Ischemic Heart Disease: Evolving Knowledge. J. Am. Coll. Cardiol. 54, 1561\u20131575 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"19436_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"WG Investigators","year":"2002","unstructured":"Investigators, W. G. for the W. H. I. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women\u2019s Health Initiative Randomized Controlled Trial. JAMA 288, 321\u2013333 (2002).","journal-title":"JAMA"},{"key":"19436_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0014-5793(97)01179-4","volume":"416","author":"C Grohe","year":"1997","unstructured":"Grohe, C. et al. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416, 107\u2013112 (1997).","journal-title":"FEBS Lett"},{"key":"19436_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/01.CIR.98.3.256","volume":"98","author":"JD Marsh","year":"1998","unstructured":"Marsh, J. D. et al. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98, 256\u2013261 (1998).","journal-title":"Circulation"},{"key":"19436_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000204096","volume":"23","author":"E Lizotte","year":"2009","unstructured":"Lizotte, E., Grandy, S. A., Tremblay, A., Allen, B. G. & Fiset, C. Expression, distribution and regulation of sex steroid hormone receptors in mouse heart. Cell Physiol Biochem 23, 75\u201386 (2009).","journal-title":"Cell Physiol Biochem"},{"key":"19436_CR8","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1096\/fj.05-5148com","volume":"20","author":"S Mahmoodzadeh","year":"2006","unstructured":"Mahmoodzadeh, S. et al. Estrogen receptor alpha up-regulation and redistribution in human heart failure. FASEB J 20, 926\u2013934 (2006).","journal-title":"FASEB J"},{"key":"19436_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger, V. L. Epidemiology of heart failure. Circ. Res. 113, 646\u2013659 (2013).","journal-title":"Circ. Res."},{"key":"19436_CR10","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1056\/NEJMra021498","volume":"348","author":"M Jessup","year":"2003","unstructured":"Jessup, M. & Brozena, S. Heart Failure. N. Engl. J. Med. 348, 2007\u20132018 (2003).","journal-title":"N. Engl. J. Med."},{"key":"19436_CR11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacc.2008.12.007","volume":"53","author":"MT Maeder","year":"2009","unstructured":"Maeder, M. T. & Kaye, D. M. Heart failure with normal left ventricular ejection fraction. J. Am. Coll. Cardiol. 53, 905\u2013918 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"19436_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","volume":"47","author":"CW Yancy","year":"2006","unstructured":"Yancy, C. W. et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J. Am. Coll. Cardiol. 47, 76\u201384 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"19436_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/01.CIR.0000117292.19349.D0","volume":"109","author":"NK Wenger","year":"2004","unstructured":"Wenger, N. K. You\u2019ve Come a Long Way, Baby. Circulation 109, 558\u2013560 (2004).","journal-title":"Circulation"},{"key":"19436_CR14","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","volume":"106","author":"DM Lloyd-Jones","year":"2002","unstructured":"Lloyd-Jones, D. M. et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106, 3068\u20133072 (2002).","journal-title":"Circulation"},{"key":"19436_CR15","first-page":"1109","volume":"51","author":"E Gerdts","year":"2008","unstructured":"Gerdts, E. et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertens. Dallas Tex 1979 51, 1109\u20131114 (2008).","journal-title":"Hypertens. Dallas Tex 1979"},{"issue":"Suppl 1","key":"19436_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003495-198400281-00002","volume":"28","author":"WB Kannel","year":"1984","unstructured":"Kannel, W. B., McGee, D. L. & Schatzkin, A. An epidemiological perspective of sudden death. 26-year follow-up in the Framingham Study. Drugs 28(Suppl 1), 1\u201316 (1984).","journal-title":"Drugs"},{"key":"19436_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4065\/84.3.289","volume":"84","author":"BA Koplan","year":"2009","unstructured":"Koplan, B. A. & Stevenson, W. G. Ventricular tachycardia and sudden cardiac death. Mayo Clin. Proc. 84, 289\u2013297 (2009).","journal-title":"Mayo Clin. Proc."},{"key":"19436_CR18","doi-asserted-by":"crossref","unstructured":"Liu, L. & Eisen, H. J. Epidemiology of heart failure and scope of the problem. Cardiol. Clin. 32, 1\u20138, vii (2014).","DOI":"10.1016\/j.ccl.2013.09.009"},{"key":"19436_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijcard.2009.11.037","volume":"149","author":"L Liu","year":"2011","unstructured":"Liu, L. Changes in cardiovascular hospitalization and comorbidity of heart failure in the United States: findings from the National Hospital Discharge Surveys 1980\u20132006. Int. J. Cardiol. 149, 39\u201345 (2011).","journal-title":"Int. J. Cardiol."},{"key":"19436_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/FJC.0b013e3181b2b6d4","volume":"54","author":"J Kurokawa","year":"2009","unstructured":"Kurokawa, J. & Abriel, H. Neurohormonal regulation of cardiac ion channels in chronic heart failure. J. Cardiovasc. Pharmacol. 54, 98\u2013105 (2009).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"19436_CR21","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1073\/pnas.97.2.931","volume":"97","author":"P Paradis","year":"2000","unstructured":"Paradis, P., Dali-Youcef, N., Paradis, F., Thibault, G. & Nemer, M. Overexpression of angiotensin II type 1 receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci 97, 931\u2013936 (2000).","journal-title":"Proc Natl Acad Sci"},{"key":"19436_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cvr\/cvn020","volume":"78","author":"K Rivard","year":"2008","unstructured":"Rivard, K., Paradis, P., Nemer, M. & Fiset, C. Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization. Cardiovasc Res 78, 53\u201362 (2008).","journal-title":"Cardiovasc Res"},{"key":"19436_CR23","doi-asserted-by":"publisher","first-page":"H2018","DOI":"10.1152\/ajpheart.01092.2010","volume":"301","author":"K Rivard","year":"2011","unstructured":"Rivard, K. et al. Overexpression of type 1 angiotensin II receptors impairs excitation-contraction coupling in the mouse heart. Am J Physiol Heart Circ Physiol 301, H2018\u2013H2027 (2011).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"19436_CR24","doi-asserted-by":"publisher","first-page":"000","DOI":"10.1016\/j.hrthm.2016.02.015","volume":"13","author":"S Mathieu","year":"2016","unstructured":"Mathieu, S. et al. Reduction in Na+ current by Angiotensin II is mediated by PKC\u03b1 in mouse and human induced pluripotent stem cells-derived cardiomyocytes. Heart Rhythm 13, 000\u2013000 (2016).","journal-title":"Heart Rhythm"},{"key":"19436_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yjmcc.2011.09.002","volume":"52","author":"E Fares","year":"2012","unstructured":"Fares, E., Parks, R. J., Macdonald, J. K., Egar, J. M. S. & Howlett, S. E. Ovariectomy enhances SR Ca2+ release and increases Ca2+ spark amplitudes in isolated ventricular myocytes. J. Mol. Cell. Cardiol. 52, 32\u201342 (2012).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"19436_CR26","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCULATIONAHA.111.023838","volume":"125","author":"R Deo","year":"2012","unstructured":"Deo, R. & Albert, C. M. Epidemiology and genetics of sudden cardiac death. Circulation 125, 620\u2013637 (2012).","journal-title":"Circulation"},{"key":"19436_CR27","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/01.CIR.93.6.1170","volume":"93","author":"CM Albert","year":"1996","unstructured":"Albert, C. M., McGovern, B. A., Newell, J. B. & Ruskin, J. N. Sex differences in cardiac arrest survivors. Circulation 93, 1170\u20131176 (1996).","journal-title":"Circulation"},{"key":"19436_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/CIRCULATIONAHA.113.007149","volume":"129","author":"JJ Goldberger","year":"2014","unstructured":"Goldberger, J. J. et al. Risk stratification for sudden cardiac death: a plan for the future. Circulation 129, 516\u2013526 (2014).","journal-title":"Circulation"},{"key":"19436_CR29","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1161\/hc4701.099784","volume":"104","author":"C Kim","year":"2001","unstructured":"Kim, C., Fahrenbruch, C. E., Cobb, L. A. & Eisenberg, M. S. Out-of-hospital cardiac arrest in men and women. Circulation 104, 2699\u20132703 (2001).","journal-title":"Circulation"},{"key":"19436_CR30","first-page":"1843","volume":"99","author":"AE Buxton","year":"1999","unstructured":"Buxton, A. E. et al. Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variables. Circulation 99, 1843\u20131850 (1999).","journal-title":"Utility of clinical variables. Circulation"},{"key":"19436_CR31","unstructured":"Bashore, T. M., Granger, C. B., Jackson, K. & Patel, M. R. Heart Disease. In Current Medical Diagnosis & Treatment 2016 (eds Papadakis, M. A., McPhee, S. J. & Rabow, M. W.) (McGraw-Hill Education, 2015)."},{"key":"19436_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12248-z","volume":"7","author":"P Ren","year":"2017","unstructured":"Ren, P. et al. Critical Role of ADAMTS-4 in the Development of Sporadic Aortic Aneurysm and Dissection in Mice. Sci. Rep. 7, 12351 (2017).","journal-title":"Sci. Rep."},{"key":"19436_CR33","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1161\/HYPERTENSIONAHA.117.09822","volume":"70","author":"T Kawai","year":"2017","unstructured":"Kawai, T. et al. Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II\/\u03b2-Aminopropionitrile\u2013Induced Abdominal Aortic Aneurysm. Hypertension 70, 959\u2013963 (2017).","journal-title":"Hypertension"},{"key":"19436_CR34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jvs.2013.11.004","volume":"61","author":"X Zhang","year":"2015","unstructured":"Zhang, X., Thatcher, S., Wu, C., Daugherty, A. & Cassis, L. A. Castration of male mice prevents the progression of established angiotensin II-induced abdominal aortic aneurysms. J. Vasc. Surg. 61, 767\u2013776 (2015).","journal-title":"J. Vasc. Surg."},{"key":"19436_CR35","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1161\/ATVBAHA.107.160382","volume":"28","author":"T Henriques","year":"2008","unstructured":"Henriques, T., Zhang, X., Yiannikouris, F. B., Daugherty, A. & Cassis, L. A. Androgen Increases AT1a Receptor Expression in Abdominal Aortas to Promote Angiotensin II-Induced AAAs in Apolipoprotein E Deficient Mice. Arterioscler. Thromb. Vasc. Biol. 28, 1251\u20131256 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"19436_CR36","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1161\/CIRCRESAHA.111.253880","volume":"110","author":"X Zhang","year":"2012","unstructured":"Zhang, X. et al. Transient Exposure of Neonatal Female Mice to Testosterone Abrogates the Sexual Dimorphism of Abdominal Aortic Aneurysms. Circ. Res. 110, e73\u2013e85 (2012).","journal-title":"Circ. Res."},{"key":"19436_CR37","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","volume":"116","author":"L Te Riet","year":"2015","unstructured":"Te Riet, L., van Esch, J. H., Roks, A. J., van den Meiracker, A. H. & Danser, A. H. Hypertension: Renin\u2013Angiotensin\u2013Aldosterone System Alterations. Circ. Res. 116, 960\u2013975 (2015).","journal-title":"Circ. Res."},{"key":"19436_CR38","unstructured":"Fischer, R. et al. Angiotensin II-induced sudden arrhythmic death and electrical remodeling. AJP - Heart Circ. Physiol. 01400 (2007)."},{"key":"19436_CR39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.hrthm.2010.09.079","volume":"8","author":"XHT Wehrens","year":"2011","unstructured":"Wehrens, X. H. T. CaMKII Regulation of the Cardiac Ryanodine Receptor and SR Calcium Release. Heart Rhythm. 8, 323\u2013325 (2011).","journal-title":"Heart Rhythm."},{"key":"19436_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.physiol.67.040403.114521","volume":"67","author":"XHT Wehrens","year":"2005","unstructured":"Wehrens, X. H. T., Lehnart, S. E. & Marks, A. R. Intracellular calcium release and cardiac disease. Annu. Rev. Physiol. 67, 69\u201398 (2005).","journal-title":"Annu. Rev. Physiol."},{"key":"19436_CR41","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/apha.12766","volume":"219","author":"U Gergs","year":"2017","unstructured":"Gergs, U. et al. Evidence for a functional role of calsequestrin 2 in mouse atrium. Acta Physiol. 219, 671\u2013684 (2017).","journal-title":"Acta Physiol."},{"key":"19436_CR42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.hrthm.2016.10.019","volume":"14","author":"T Kato","year":"2017","unstructured":"Kato, T. et al. Correction of impaired calmodulin binding to RyR2 as a novel therapy for lethal arrhythmia in the pressure-overloaded heart failure. Heart Rhythm 14, 120\u2013127 (2017).","journal-title":"Heart Rhythm"},{"key":"19436_CR43","doi-asserted-by":"crossref","unstructured":"Lugenbiel, P. et al. Atrial Fibrillation Complicated by Heart Failure Induces Distinct Remodeling of Calcium Cycling Proteins. PLoS ONE 10 (2015).","DOI":"10.1371\/journal.pone.0116395"},{"key":"19436_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCRESAHA.108.189779","volume":"105","author":"K Gusev","year":"2009","unstructured":"Gusev, K. et al. Angiotensin II-mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling. Circ Res 105, 42\u201350 (2009).","journal-title":"Circ Res"},{"key":"19436_CR45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm1000","volume":"10","author":"JC Braz","year":"2004","unstructured":"Braz, J. C. et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10, 248\u2013254 (2004).","journal-title":"Nat. Med."},{"key":"19436_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/hh1701.095644","volume":"89","author":"V Tr\u00e9panier-Boulay","year":"2001","unstructured":"Tr\u00e9panier-Boulay, V., St-Michel, C., Tremblay, A. & Fiset, C. Gender-based differences in cardiac repolarization in mouse ventricle. Circ. Res. 89, 437\u2013444 (2001).","journal-title":"Circ. Res."},{"key":"19436_CR47","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1113\/jphysiol.2004.063446","volume":"559","author":"J Brouillette","year":"2004","unstructured":"Brouillette, J., Clark, R. B., Giles, W. R. & Fiset, C. Functional properties of K+ currents in adult mouse ventricular myocytes. J. Physiol. 559, 777\u2013798 (2004).","journal-title":"J. Physiol."},{"key":"19436_CR48","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1540-8167.2009.01713.x","volume":"21","author":"SA Grandy","year":"2010","unstructured":"Grandy, S. A., Brouillette, J. & Fiset, C. Reduction of ventricular sodium current in a mouse model of HIV. J Cardiovasc Electrophysiol 21, 916\u2013922 (2010).","journal-title":"J Cardiovasc Electrophysiol"},{"key":"19436_CR49","doi-asserted-by":"publisher","first-page":"21896","DOI":"10.1074\/jbc.M114.549642","volume":"289","author":"N El Khoury","year":"2014","unstructured":"El Khoury, N., Mathieu, S. & Fiset, C. Interleukin-1\u03b2 reduces L-type Ca2+ current through protein kinase C\u03f5 activation in mouse heart. J. Biol. Chem. 289, 21896\u201321908 (2014).","journal-title":"J. Biol. Chem."},{"key":"19436_CR50","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.1073\/pnas.0401833101","volume":"101","author":"A Aries","year":"2004","unstructured":"Aries, A., Paradis, P., Lefebvre, C., Schwartz, R. J. & Nemer, M. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc Natl Acad Sci U A 101, 6975\u20136980 (2004).","journal-title":"Proc Natl Acad Sci U A"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19436-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19436-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19436-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T12:32:34Z","timestamp":1719750754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19436-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19436"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19436-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"assertion":[{"value":"1 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"952"}}